Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0I0GM
|
||||
Former ID |
DIB004728
|
||||
Drug Name |
Daxalipram
|
||||
Synonyms |
Mesopram; SH-636; ZK-117137; PDE 4 inhibitor (multiple sclerosis), Schering AG
|
||||
Indication | Multiple scierosis [ICD9: 340; ICD10:G35] | Discontinued in Phase 2 | [547377] | ||
Company |
Bayer Schering Pharma AG
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
C1(=O)O[C@](c2cc(c(cc2)OC)OCCC)(CN1)C
|
||||
CAS Number |
CAS 189940-24-7
|
||||
Target and Pathway | |||||
Target(s) | Type IV phosphodiesterase | Target Info | Inhibitor | [532832] | |
CAMP-specific 3',5'-cyclic phosphodiesterase 4B | Target Info | Inhibitor | [532832] | ||
CAMP-specific 3',5'-cyclic phosphodiesterase 4A | Target Info | Inhibitor | [532832] | ||
NetPath Pathway | IL5 Signaling Pathway | ||||
IL2 Signaling Pathway | |||||
PathWhiz Pathway | Purine Metabolism | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.